NKX3-1 and prostate cancer: In summary, we provided in vitro and in vivo evidence to elucidate that YTHDF2 mediates the mRNA degradation of the tumor suppressors LHPP and NKX3–1 in m6A-depnedent way to regulate AKT phosphorylation-induced tumor progression in prostate cancer.